-
Russian medical center finishes pre-clinical trials of nasal spray coronavirus vaccine
The Russia’s Gamaleya Center’s Director Alexander Gintsburg told Russian news website the TASS, the center has completed pre-clinical trials of a nasal spray coronavirus vaccine and are ready to launch clinical trials.
He said: "There has been serious progress made in terms of the nasal spray vaccine, pre-clinical trials are over. We are ready to move on to clinical trials."
The TASS reported according to Gintsburg, the nasal spray vaccine consists of the second component of the Sputnik V vaccine.
Read more: Covid-19 hospitalisation rates for children in US reach highest levels ever
It should be noted that the Gamaleya Center’s director said earlier that clinical trials could begin in late 2021 or early 2022 and the vaccine was expected to be approved in 2022.
Source: tass
